Jane E Churpek
Overview
Explore the profile of Jane E Churpek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1733
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kindler H, Ismaila N, Bazhenova L, Chu Q, Churpek J, Dagogo-Jack I, et al.
J Clin Oncol
. 2025 Jan;
43(8):1006-1038.
PMID: 39778125
Purpose: To provide evidence-based recommendations to practicing physicians and others on the management of pleural mesothelioma (PM). Methods: ASCO convened an Expert Panel of medical oncology, thoracic surgery, radiation oncology,...
2.
Aakash F, Gisriel S, Zeidan A, Bennett J, Bejar R, Bewersdorf J, et al.
Mod Pathol
. 2024 Sep;
37(12):100615.
PMID: 39322118
Myelodysplastic neoplasms/syndromes (MDS) are a heterogeneous group of biologically distinct entities characterized by variable degrees of ineffective hematopoiesis. Recently, 2 classification systems (the 5th edition of the World Health Organization...
3.
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms
Kaur A, Rojek A, Symes E, Nawas M, Patel A, Patel J, et al.
Blood Cancer J
. 2024 Jun;
14(1):99.
PMID: 38890297
Current therapies for high-grade TP53-mutated myeloid neoplasms (≥10% blasts) do not offer a meaningful survival benefit except allogeneic stem cell transplantation in the minority who achieve a complete response to...
4.
Banaszak L, Cabral P, Smith-Simmer K, Hassan A, Brunner M, Fallon M, et al.
JCO Precis Oncol
. 2024 Jun;
8:e2300518.
PMID: 38848520
Purpose: Knowledge of an inherited predisposition to myelodysplastic syndrome (MDS) and AML has important clinical implications for treatment decisions, surveillance, and care of at-risk relatives. National Comprehensive Cancer Network (NCCN)...
5.
Bansal V, Mitchell O, Bregio C, Witmer H, Dhiman A, Godley 4th F, et al.
Ann Surg Oncol
. 2024 Feb;
31(5):3339-3349.
PMID: 38372861
Introduction: Venous thromboembolism (VTE) is a common complication in patients with abdominal malignancies. Despite known associations between pleural mesothelioma and increased VTE risk, the characteristics of VTE in patients with...
6.
Banaszak L, Smith-Simmer K, Shoger K, Lovrien L, Malik A, Sandbo N, et al.
Respir Med
. 2023 Nov;
220:107464.
PMID: 37951311
Introduction: Patients with interstitial lung disease (ILD) secondary to telomere biology disorders (TBD) experience increased morbidity after lung transplantation. Identifying patients with TBD may allow for personalized management to facilitate...
7.
Stahl M, Bewersdorf J, Xie Z, Della Porta M, Komrokji R, Xu M, et al.
Blood Rev
. 2023 Sep;
62:101128.
PMID: 37704469
The guidelines for classification, prognostication, and response assessment of myelodysplastic syndromes/neoplasms (MDS) have all recently been updated. In this report on behalf of the International Consortium for MDS (icMDS) we...
8.
Kilbride M, Egleston B, Chung W, Olopade O, Maxwell K, Shah P, et al.
J Clin Oncol
. 2023 Aug;
41(31):4905-4915.
PMID: 37611220
Purpose: We developed a web-based education intervention as an alternative to predisclosure education with a genetic counselor (GC) to reduce participant burden and provider costs with return of genetic research...
9.
Mitchell O, Gilliam K, Del Gaudio D, McNeely K, Smith S, Acevedo M, et al.
JAMA Netw Open
. 2023 Aug;
6(8):e2327351.
PMID: 37556141
Importance: Patients with mesothelioma often have next-generation sequencing (NGS) of their tumor performed; tumor-only NGS may incidentally identify germline pathogenic or likely pathogenic (P/LP) variants despite not being designed for...
10.
Reinig E, Rubinstein J, Patil A, Schussman A, Horner V, Kanagal-Shamanna R, et al.
Leukemia
. 2023 Jul;
37(8):1589-1599.
PMID: 37393344
Myeloid malignancies associated with germline predisposition syndromes account for up to 10% of myeloid neoplasms. They are classified into three categories by the proposed 5 Edition of the World Health...